Lymphoma Treatment

Advanced Cancer Treatment at CMN Hospital

Lymphoma is a cancer of the lymphatic system, a vital part of the body’s immune system that includes the lymph nodes, spleen, thymus gland, bone marrow, and lymphatic vessels. It develops when lymphocytes, a type of white blood cell, grow abnormally and accumulate in the lymphatic system or other organs.

There are more than 70 recognized subtypes of lymphoma. The two primary categories are Hodgkin lymphoma and Non-Hodgkin lymphoma, with Non-Hodgkin lymphoma accounting for the majority of lymphoma diagnoses.

Hodgkin Lymphoma

Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells and often begins in the lymph nodes of the neck, chest, or underarms.

Common subtypes include:

  • Classical Hodgkin Lymphoma
  • Nodular Sclerosis Hodgkin Lymphoma
  • Mixed Cellularity Hodgkin Lymphoma
  • Lymphocyte-Rich Hodgkin Lymphoma
  • Lymphocyte-Depleted Hodgkin Lymphoma
  • Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma is a diverse group of cancers affecting B lymphocytes, T lymphocytes, or natural killer cells. Some forms grow slowly, while others are more aggressive and require prompt medical attention.

Common B-cell lymphomas include:

  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Burkitt Lymphoma
  • Primary Mediastinal B-Cell Lymphoma
  • Small Lymphocytic Lymphoma
  • Waldenström Macroglobulinemia

Common T-cell and NK-cell lymphomas include:

  • Peripheral T-Cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Angioimmunoblastic T-Cell Lymphoma
  • Cutaneous T-Cell Lymphoma
  • Mycosis Fungoides
  • Sézary Syndrome
  • Extranodal NK/T-Cell Lymphoma

Individualized Physician Review

At CMN Hospital, every patient is evaluated individually. Dr. Edgar Payán, General Hospital Director and Medical Director of CMN Hospital, personally reviews each patient’s pathology reports, biopsy results, imaging studies, laboratory findings, treatment history, current health status, and other relevant medical records before discussing whether CMN Hospital’s 28-day inpatient Advanced Cancer Treatment program may be appropriate.

During the consultation, Dr. Payán explains the findings, answers questions, and discusses treatment options based on each patient’s individual diagnosis and overall medical condition.